Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119469) titled 'Real-World Study on Immunotherapy for Refractory Autoimmune Encephalitis' on Feb. 27.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Renji Hospital,Shanghai Jiaotong University School of Medicine

Condition: Autoimmune encephalitis

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2025-01-07

Target Sample Size: second-line immunotherapy:100;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=266789

Published by HT Digital Content Services with permission from Health Daily Digest....